Skip to main content
Petros Karakousis, MD, Infectious Disease, Baltimore, MD

Petros Constantine Karakousis MD


Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile
  • 1800 Orleans StreetBaltimore, MD 21287

  • Phone+1 410-955-5000

  • Fax+1 410-955-5001

Dr. Karakousis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 2002 - 2005
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
  • WashU Medicine
    WashU MedicineClass of 1998
  • Johns Hopkins University
    Johns Hopkins UniversityB.A., Summa Cum Laude, 1994

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2005 - 2026
  • PA State Medical License
    PA State Medical License 1999 - 2002
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Member American Society of Clinical Investigation, 2021
  • American Society of Clinical Investigation 2021
  • CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genome analysis of Mycobacterium avium subspecies hominissuis strain 109  
    Matern WM, Bader JS, Karakousis PC, Sci Data, 1/1/2018
  • Unprecedented in Vitro Antitubercular Activitiy of Manganese(II) Complexes Containing 1, 10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Sele...  
    McCarron P, McCann M, Devereux M, Kavanagh K, Skerry C, Karakousis PC, Aor AC, Mello TP, Santos ALS, Campos DL, Pavan FR, Front Microbiol, 1/1/2018
  • Gene enrichment analysis reveals major regulators of Mycobacterium tuberculosis gene expression in two models of antibiotic tolerance  
    Matern WM, Rifat D, Bader J, Karakousis PC, Front Microbiol, 1/1/2018

Books/Book Chapters

Lectures

  • "Overview of Tuberculosis" 
    1/1/2019
  • "Animal models of TB infection." 
    1/1/2019
  • "Tuberculosis and Antimicrobials" 
    JHUSOM (Johns Hopkins University School of Medicine), 2012-2019 - 1/1/2019

Other

  • "XDR-TB Scare" 
    Karakousis PC, Fox National News (11:00 AM, Thursday)
    1/31/2007
  • Greetings from sunny (most of the time) San Diego: Highlights from the 41st Annual Meeting of the Infectious Diseases Society of America. 
    Karakousis PC, Page KR, Bishai WR, JHU (Johns Hopkins University)Antibiotic Guide Website
    http://hopkins-abxguide.org
    1/1/2003
  • Synopsis of key presentations at the 40th Annual Meeting of IDSA (October 24-27, 2002, Chicago). 
    Karakousis PC, Bishai WR, JHU (Johns Hopkins University)Antibiotic Guide Website
    http://hopkins-abxguide.org
    1/1/2002

Press Mentions

  • Why You Should Get Vaccinated Against COVID-19 if You Take Statins
    Why You Should Get Vaccinated Against COVID-19 if You Take StatinsNovember 2nd, 2021
  • Statins Not Beneficial for Preventing COVID-19 Mortality
    Statins Not Beneficial for Preventing COVID-19 MortalityNovember 2nd, 2021
  • Do Cholesterol Drugs Reduce COVID Risks? Study Findings Are Conflicting. Here’s Why
    Do Cholesterol Drugs Reduce COVID Risks? Study Findings Are Conflicting. Here’s WhyOctober 27th, 2021

Grant Support

  • Advancing Apoptosis-Inducing Agents as Host-Directed Therapy for TBJOHNS HOPKINS UNIVERSITY2025–2029
  • JHU TRAC: Training and Supporting the Next Generation of TB ResearchersJOHNS HOPKINS UNIVERSITY2022–2027
  • Characterizing CaeA-mediated rifampin tolerance in MTBJOHNS HOPKINS UNIVERSITY2022–2025
  • Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persistersJOHNS HOPKINS UNIVERSITY2020–2025
  • Mentoring in Immunometabolic Dysregulation in TB and TB/HIVJOHNS HOPKINS UNIVERSITY2019–2025

Other Languages

  • Greek, Spanish, German, Russian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: